Related Experiment Videos
Cockayne syndrome and xeroderma pigmentosum.
I Rapin1, Y Lindenbaum, D W Dickson
1Department of Neurology, Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine,Bronx, NY, USA. rapin@aecom.yu.edu
Neurology
|February 24, 2001
Summary
Cockayne syndrome (CS) and xeroderma pigmentosum (XP) are DNA repair disorders affecting the nervous system. The rare xeroderma pigmentosum-Cockayne syndrome (XP-CS) complex often presents with severe CS features despite XP genotype, highlighting unexplained phenotype-genotype discrepancies.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Cockayne syndrome (CS) and xeroderma pigmentosum (XP) are autosomal recessive DNA repair disorders.
- Both conditions significantly impact the nervous system.
- The xeroderma pigmentosum-Cockayne syndrome (XP-CS) complex represents a rare intersection of these disorders.
Purpose of the Study:
- To review genetic variants of CS and XP.
- To examine their neurological manifestations.
- To present neuropathologic findings of an XP-CS complex case.
Main Methods:
- Review of published clinical, pathologic, and molecular studies.
- Inclusion of a ninth case of XP-CS for summary.
- Analysis of cellular responses to UV radiation.
Main Results:
- CS causes growth failure, cachexia, and neurodegeneration.
- XP is characterized by extreme photosensitivity and increased cancer risk; some patients develop neurodegeneration.
- XP-CS patients often exhibit severe CS phenotypes despite XP genotype, with extreme UV sensitivity and deficient DNA repair.
Conclusions:
- The phenotype-genotype correlation in CS and XP is paradoxical and unexplained.
- Mutations affecting DNA repair and transcription may influence growth, aging, and neurodegeneration.
- Further research is needed to understand these complex mechanisms.